NCT01943552 - Ipratropium Bromide in Peri-Operative COPD | Biotech Hunter

Enrollment

192

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

placebo

normal saline

DRUG

ipratropium bromide

Trial Locations (9)

244.2514.86008 Boehringer Ingelheim Investigational Site, Chengdu

244.2514.86006 Boehringer Ingelheim Investigational Site, Guangzhou

244.2514.86007 Boehringer Ingelheim Investigational Site, Guangzhou

244.2514.86010 Boehringer Ingelheim Investigational Site, Guangzhou

244.2514.86009 Boehringer Ingelheim Investigational Site, Hangzhou

244.2514.86004 Boehringer Ingelheim Investigational Site, Shanghai

244.2514.86002 Boehringer Ingelheim Investigational Site, Tianjin

244.2514.86011 Boehringer Ingelheim Investigational Site, Wuhan

244.2514.86012 Boehringer Ingelheim Investigational Site, Wuhan